Ryaltris - Mometasone furoate with olopatadine hydrochloride
Glenmark Pharmaceuticals Europe Ltd.
Description
For treatment of moderate to severe nasal symptoms associated with allergic rhinitis in adults and adolescents of 12 years of age and older.
- Adults and adolescents of 12 years of age and older: two actuations into each nostril, twice daily
Indications
For treatment of moderate to severe nasal symptoms associated with allergic rhinitis.
Preparations Available
Spray
Sizes Available
Ryaltris 25 mcg/ 600 mcg per actuation, 240 doses per bottle
More on: Nasal preparations , Corticosteroids , Antihistamines , Non-sedating antihistamines